Header Logo

Michael Liptay

Concepts (358)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
67
2022
552
8.180
Why?
Carcinoma, Non-Small-Cell Lung
48
2021
244
5.950
Why?
Pneumonectomy
28
2022
77
3.230
Why?
Lymph Nodes
9
2015
70
2.020
Why?
Sentinel Lymph Node Biopsy
9
2015
22
2.010
Why?
Neoplasm Staging
35
2021
372
1.550
Why?
Radiopharmaceuticals
7
2009
54
1.450
Why?
Biomarkers, Tumor
10
2022
202
1.040
Why?
Adenocarcinoma
8
2014
145
1.030
Why?
Thoracic Surgery, Video-Assisted
5
2015
22
1.010
Why?
Mesothelioma
6
2012
14
0.990
Why?
Humans
92
2022
28554
0.930
Why?
Esophageal Neoplasms
4
2011
54
0.880
Why?
Lymphatic Metastasis
13
2015
91
0.850
Why?
Carcinoma, Squamous Cell
5
2019
176
0.850
Why?
Neoadjuvant Therapy
8
2015
66
0.830
Why?
Bronchoscopy
6
2019
34
0.820
Why?
Postoperative Complications
12
2022
934
0.810
Why?
Pleural Neoplasms
6
2012
11
0.760
Why?
Technetium Tc 99m Sulfur Colloid
4
2009
8
0.750
Why?
Neoplasm Recurrence, Local
8
2017
206
0.720
Why?
Aged
48
2021
9344
0.720
Why?
Respiration, Artificial
1
2021
114
0.670
Why?
Male
55
2021
15401
0.670
Why?
Prognosis
18
2022
827
0.650
Why?
Female
53
2021
15821
0.650
Why?
Small Cell Lung Carcinoma
1
2019
9
0.650
Why?
False Positive Reactions
1
2019
36
0.640
Why?
Thoracic Surgery
7
2022
27
0.640
Why?
Unnecessary Procedures
1
2019
30
0.630
Why?
Middle Aged
44
2021
9322
0.580
Why?
Mediastinal Neoplasms
2
2009
11
0.540
Why?
Carcinoma, Bronchogenic
1
2015
6
0.500
Why?
Risk Assessment
10
2021
676
0.490
Why?
Anastomosis, Surgical
2
2011
30
0.470
Why?
Aged, 80 and over
22
2018
4901
0.430
Why?
Breast Neoplasms
2
2007
410
0.420
Why?
Treatment Outcome
21
2017
3622
0.410
Why?
Mediastinitis
2
2009
6
0.410
Why?
Adult
27
2017
8173
0.400
Why?
Solitary Pulmonary Nodule
3
2015
15
0.390
Why?
Pulmonary Diffusing Capacity
3
2016
9
0.390
Why?
Mediastinal Diseases
1
2012
4
0.390
Why?
Carbon Monoxide
2
2022
7
0.390
Why?
Histoplasmosis
1
2012
8
0.390
Why?
Survival Rate
11
2021
356
0.390
Why?
Chemoradiotherapy
6
2015
61
0.390
Why?
Esophagectomy
1
2011
24
0.380
Why?
Practice Management, Medical
1
2011
2
0.380
Why?
Airway Obstruction
2
2017
20
0.360
Why?
Survival Analysis
11
2017
267
0.350
Why?
Xanthine Dehydrogenase
1
2010
6
0.350
Why?
Antineoplastic Combined Chemotherapy Protocols
6
2015
244
0.350
Why?
Colon
1
2011
144
0.350
Why?
Predictive Value of Tests
7
2014
496
0.340
Why?
Colorectal Neoplasms
2
2009
113
0.340
Why?
Aspergillus flavus
1
2009
4
0.340
Why?
Mediastinum
1
2009
7
0.330
Why?
Aspergillosis
1
2009
13
0.330
Why?
Gene Expression Regulation, Neoplastic
1
2010
113
0.330
Why?
Retrospective Studies
17
2022
3615
0.330
Why?
Early Detection of Cancer
5
2022
105
0.320
Why?
Tomography, X-Ray Computed
9
2015
772
0.320
Why?
Diagnosis, Differential
8
2018
373
0.320
Why?
Carcinoid Tumor
1
2008
6
0.320
Why?
Gastrointestinal Stromal Tumors
1
2009
30
0.310
Why?
Monitoring, Intraoperative
1
2009
37
0.310
Why?
Carcinoma, Neuroendocrine
1
2008
13
0.310
Why?
Device Removal
2
2008
92
0.300
Why?
Diagnostic Imaging
1
2009
80
0.300
Why?
Catheterization
2
2007
45
0.300
Why?
Neoplasms, Second Primary
1
2008
40
0.300
Why?
Preoperative Care
4
2015
125
0.300
Why?
Cohort Studies
10
2018
1942
0.290
Why?
Pleural Effusion, Malignant
1
2007
4
0.290
Why?
Neoplasms, Multiple Primary
2
2009
41
0.290
Why?
Genital Neoplasms, Female
1
2007
14
0.290
Why?
Positron-Emission Tomography
1
2008
90
0.290
Why?
Combined Modality Therapy
8
2015
308
0.280
Why?
Follow-Up Studies
11
2021
1863
0.260
Why?
Multivariate Analysis
7
2017
333
0.260
Why?
Multiple Pulmonary Nodules
2
2018
12
0.250
Why?
Insulin-Like Growth Factor I
3
2022
59
0.250
Why?
Immunoassay
2
2018
40
0.250
Why?
Radionuclide Imaging
4
2009
43
0.230
Why?
Lung
3
2022
170
0.230
Why?
Superior Vena Cava Syndrome
1
2003
5
0.220
Why?
Thoracoscopy
5
2019
23
0.220
Why?
Disease-Free Survival
6
2017
177
0.220
Why?
Cesarean Section
1
2003
30
0.220
Why?
Lymphoma, Non-Hodgkin
1
2003
37
0.210
Why?
Insulin-Like Growth Factor Binding Proteins
2
2014
10
0.210
Why?
Lymph Node Excision
4
2015
27
0.210
Why?
Thoracic Wall
2
2016
12
0.210
Why?
Stents
2
2017
86
0.210
Why?
Technetium Compounds
1
2002
1
0.210
Why?
Tin Compounds
1
2002
1
0.210
Why?
Databases, Factual
7
2021
359
0.210
Why?
Registries
2
2021
188
0.200
Why?
Weight Gain
2
2012
66
0.190
Why?
Biopsy
4
2012
220
0.180
Why?
Tidal Volume
1
2021
13
0.180
Why?
Pneumonia
2
2019
77
0.170
Why?
Sensitivity and Specificity
4
2018
520
0.170
Why?
Kaplan-Meier Estimate
5
2012
180
0.170
Why?
Risk Factors
8
2022
2414
0.170
Why?
DNA Methylation
2
2012
164
0.170
Why?
Patient Selection
1
2021
207
0.170
Why?
Autoantibodies
2
2010
80
0.170
Why?
Algorithms
6
2014
380
0.170
Why?
Gases
1
2019
5
0.160
Why?
Histiocytoma, Benign Fibrous
1
1999
5
0.160
Why?
Esophagus
2
2011
65
0.160
Why?
Feasibility Studies
3
2009
233
0.160
Why?
Mediastinoscopy
1
2019
7
0.160
Why?
Osteosarcoma
1
1999
37
0.160
Why?
History, 20th Century
2
2016
47
0.160
Why?
United States
5
2021
2191
0.160
Why?
Histocompatibility Antigens Class II
1
2018
6
0.150
Why?
Intraoperative Period
3
2004
27
0.150
Why?
HLA Antigens
1
2018
17
0.150
Why?
Syndecan-1
1
2018
4
0.150
Why?
Histocompatibility Antigens Class I
1
2018
18
0.150
Why?
Neovascularization, Pathologic
2
2015
36
0.150
Why?
Bone Neoplasms
1
1999
120
0.140
Why?
Nerve Growth Factors
1
2018
37
0.140
Why?
Tracheomalacia
1
2017
4
0.140
Why?
Tracheal Stenosis
1
2017
6
0.140
Why?
Silicones
1
2017
12
0.140
Why?
Sarcoma
2
2009
144
0.140
Why?
Area Under Curve
3
2014
63
0.130
Why?
Cardiac Surgical Procedures
1
2016
45
0.130
Why?
Ribs
1
2016
15
0.130
Why?
Metformin
1
2016
20
0.130
Why?
Cardiology
1
2016
57
0.130
Why?
Hypoglycemic Agents
1
2016
40
0.130
Why?
Proportional Hazards Models
3
2016
352
0.130
Why?
Heart Diseases
1
2016
70
0.130
Why?
Disease Progression
4
2014
722
0.130
Why?
Academic Medical Centers
1
2016
137
0.120
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2012
25
0.120
Why?
Clinical Trials as Topic
2
2012
239
0.120
Why?
Adolescent
5
2022
2323
0.120
Why?
Lung Diseases, Fungal
1
2015
10
0.120
Why?
Mucormycosis
1
2015
9
0.120
Why?
Early Medical Intervention
1
2015
15
0.120
Why?
Carcinoma
2
2015
70
0.120
Why?
Cytokines
2
2014
232
0.120
Why?
Periodicals as Topic
1
2015
42
0.120
Why?
Insulin-Like Growth Factor II
1
2014
10
0.120
Why?
Biopsy, Needle
2
2008
108
0.110
Why?
Radiotherapy, Conformal
1
2014
21
0.110
Why?
Social Class
1
2014
67
0.110
Why?
Thoracotomy
5
2016
29
0.110
Why?
Prosthesis Failure
1
2017
539
0.110
Why?
Diabetes Mellitus, Type 2
1
2016
191
0.110
Why?
Radiotherapy, Adjuvant
5
2011
52
0.110
Why?
Interleukin-2 Receptor alpha Subunit
1
2013
13
0.100
Why?
Genes, p16
1
2012
4
0.100
Why?
Carcinoma, Small Cell
2
2010
54
0.100
Why?
Time Factors
4
2019
1498
0.100
Why?
Prospective Studies
6
2021
1811
0.100
Why?
Young Adult
4
2014
2104
0.100
Why?
Esophageal Stenosis
1
2011
3
0.100
Why?
Stomach
1
2011
15
0.100
Why?
Therapies, Investigational
1
2011
5
0.100
Why?
C-Peptide
1
2011
6
0.100
Why?
Group Practice
1
2011
1
0.100
Why?
Forced Expiratory Volume
2
2009
11
0.100
Why?
Appointments and Schedules
1
2011
14
0.090
Why?
Administrative Personnel
1
2011
9
0.090
Why?
Outpatient Clinics, Hospital
1
2011
15
0.090
Why?
Analysis of Variance
4
2015
276
0.090
Why?
Mentors
1
2011
43
0.090
Why?
Antineoplastic Agents
4
2014
190
0.090
Why?
Chemotherapy, Adjuvant
4
2011
81
0.090
Why?
Length of Stay
6
2016
330
0.090
Why?
Probability
2
2008
92
0.090
Why?
Animals
4
2010
3814
0.090
Why?
Chemoradiotherapy, Adjuvant
3
2015
17
0.090
Why?
Blood Chemical Analysis
1
2010
17
0.090
Why?
Referral and Consultation
1
2011
91
0.090
Why?
Hematologic Tests
1
2010
6
0.090
Why?
Protein Array Analysis
1
2010
11
0.090
Why?
Leadership
1
2011
106
0.090
Why?
PTEN Phosphohydrolase
1
2010
7
0.090
Why?
Apoptosis Regulatory Proteins
1
2010
11
0.090
Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
2010
14
0.090
Why?
Models, Statistical
1
2010
129
0.080
Why?
Tumor Suppressor Proteins
1
2010
34
0.080
Why?
Rhabdomyosarcoma
1
2009
7
0.080
Why?
Anti-Arrhythmia Agents
1
2010
37
0.080
Why?
Pleura
2
2007
9
0.080
Why?
Fibrosis
1
2009
30
0.080
Why?
Antifungal Agents
1
2009
44
0.080
Why?
Cause of Death
1
2009
64
0.080
Why?
Carcinoma, Large Cell
1
2009
12
0.080
Why?
Poland Syndrome
1
2009
1
0.080
Why?
Thoracoplasty
1
2009
1
0.080
Why?
Smoking
1
2010
175
0.080
Why?
Soft Tissue Neoplasms
1
2009
55
0.080
Why?
Biomarkers
3
2017
601
0.080
Why?
Esophageal Fistula
1
2008
1
0.080
Why?
Silicone Elastomers
1
2008
1
0.080
Why?
Surgical Wound Dehiscence
1
2008
7
0.080
Why?
Esophageal Perforation
1
2008
8
0.080
Why?
Bronchial Fistula
1
2008
3
0.080
Why?
Prosthesis Implantation
1
2008
31
0.070
Why?
Age Factors
4
2014
789
0.070
Why?
Botulinum Toxins, Type A
1
2007
8
0.070
Why?
Intraoperative Care
1
2008
43
0.070
Why?
Fluorodeoxyglucose F18
1
2008
38
0.070
Why?
Esophageal Achalasia
1
2007
18
0.070
Why?
Atrial Fibrillation
1
2010
136
0.070
Why?
Immunohistochemistry
1
2008
364
0.070
Why?
Incidence
3
2021
774
0.070
Why?
Drainage
1
2007
49
0.070
Why?
Healthcare Disparities
1
2008
87
0.070
Why?
Delivery of Health Care
1
2008
154
0.070
Why?
Neoplasm Invasiveness
2
2017
89
0.070
Why?
Sepsis
1
2008
144
0.070
Why?
Palliative Care
1
2007
109
0.070
Why?
Radiotherapy Dosage
3
2015
117
0.060
Why?
Muscle, Skeletal
1
2009
398
0.060
Why?
Carboplatin
3
2011
24
0.060
Why?
Vinblastine
1
2004
8
0.060
Why?
Paclitaxel
3
2011
44
0.060
Why?
Societies, Medical
2
2019
153
0.060
Why?
Deoxycytidine
1
2004
23
0.060
Why?
Radiography
2
2013
651
0.060
Why?
Reoperation
1
2008
917
0.060
Why?
Cell Line, Tumor
2
2018
250
0.060
Why?
Magnetic Resonance Imaging
1
2009
1197
0.050
Why?
Patient Care Planning
1
2003
52
0.050
Why?
ROC Curve
2
2014
145
0.050
Why?
Illinois
2
2014
248
0.050
Why?
Heart Transplantation
2
1993
30
0.050
Why?
Graft Rejection
2
1993
71
0.050
Why?
Pregnancy
1
2003
341
0.050
Why?
Insulin-Like Growth Factor Binding Protein 3
1
2022
5
0.050
Why?
Lung Diseases
2
1999
46
0.050
Why?
Radiography, Thoracic
2
2012
28
0.050
Why?
Patient Discharge
1
2022
162
0.050
Why?
Etoposide
2
2011
26
0.040
Why?
Chicago
2
2016
942
0.040
Why?
Aging
1
2010
1578
0.040
Why?
Health Services Accessibility
2
2014
111
0.040
Why?
Mass Screening
1
2022
184
0.040
Why?
Electrocardiography
3
2003
119
0.040
Why?
Tomography, Emission-Computed
1
1999
9
0.040
Why?
Anesthesia, Epidural
1
1999
21
0.040
Why?
Sarcoma, Small Cell
1
1999
1
0.040
Why?
Plasmacytoma
1
1999
8
0.040
Why?
Sarcoma, Ewing
1
1999
8
0.040
Why?
Bupivacaine
1
1999
46
0.040
Why?
Pilot Projects
1
2000
438
0.040
Why?
Anesthetics, Local
1
1999
81
0.040
Why?
Radiation Injuries
1
1999
32
0.040
Why?
Case-Control Studies
2
2010
599
0.040
Why?
Postoperative Care
1
1999
140
0.040
Why?
Endoscopy
2
1997
182
0.040
Why?
Remission Induction
2
2010
90
0.040
Why?
Dilatation
1
2017
10
0.040
Why?
History, 21st Century
1
2016
24
0.030
Why?
History, 19th Century
1
2016
29
0.030
Why?
Diffusion of Innovation
1
2016
32
0.030
Why?
Pneumonia, Bacterial
1
2016
11
0.030
Why?
Tracheostomy
1
2016
27
0.030
Why?
Education, Medical, Graduate
1
2016
77
0.030
Why?
Pain, Postoperative
1
1999
316
0.030
Why?
Arrhythmias, Cardiac
1
1996
73
0.030
Why?
Neoplasm, Residual
1
2015
8
0.030
Why?
Minnesota
1
2014
9
0.030
Why?
Diabetes Mellitus
1
2016
137
0.030
Why?
Intubation, Intratracheal
1
2016
99
0.030
Why?
Actuarial Analysis
1
2014
8
0.030
Why?
Induction Chemotherapy
1
2014
13
0.030
Why?
Academies and Institutes
1
2014
10
0.030
Why?
Cancer Care Facilities
1
2014
7
0.030
Why?
Propensity Score
1
2014
36
0.030
Why?
Radiotherapy, Intensity-Modulated
1
2014
38
0.030
Why?
Patient Readmission
1
2015
134
0.030
Why?
Coronary Circulation
1
1993
26
0.030
Why?
Internship and Residency
1
2016
218
0.030
Why?
Chemokine CCL3
1
2013
9
0.030
Why?
Granuloma
1
2013
15
0.030
Why?
Interleukin 1 Receptor Antagonist Protein
1
2013
15
0.030
Why?
Chemokine CXCL12
1
2013
10
0.030
Why?
Interleukin-10
1
2013
20
0.030
Why?
Logistic Models
1
2014
398
0.030
Why?
Respiratory Tract Infections
1
2013
27
0.030
Why?
Interleukin-6
1
2013
79
0.030
Why?
Prevalence
1
2014
467
0.030
Why?
Telemetry
1
1992
11
0.020
Why?
Decision Support Techniques
1
2012
52
0.020
Why?
Epigenesis, Genetic
1
2012
85
0.020
Why?
Reproducibility of Results
1
2014
732
0.020
Why?
Tumor Necrosis Factor-alpha
1
2013
192
0.020
Why?
Digestive System Surgical Procedures
1
2011
24
0.020
Why?
Choice Behavior
1
2011
47
0.020
Why?
Medical Oncology
1
2011
43
0.020
Why?
Electrophoresis, Gel, Two-Dimensional
1
2010
10
0.020
Why?
Tandem Mass Spectrometry
1
2010
21
0.020
Why?
Serum
1
2010
7
0.020
Why?
Antibodies, Neoplasm
1
2010
13
0.020
Why?
Antigens, Neoplasm
1
2010
39
0.020
Why?
Death-Associated Protein Kinases
1
2010
4
0.020
Why?
DNA Modification Methylases
1
2010
4
0.020
Why?
Monomeric GTP-Binding Proteins
1
2010
5
0.020
Why?
DNA Repair Enzymes
1
2010
7
0.020
Why?
Immunoenzyme Techniques
1
2010
32
0.020
Why?
In Situ Hybridization, Fluorescence
1
2010
34
0.020
Why?
Cadherins
1
2010
36
0.020
Why?
Medical Records
1
2010
34
0.020
Why?
CpG Islands
1
2010
53
0.020
Why?
Antigens, CD
1
2010
52
0.020
Why?
Neoplasm Proteins
1
2010
54
0.020
Why?
Promoter Regions, Genetic
1
2010
100
0.020
Why?
Adaptor Proteins, Signal Transducing
1
2010
65
0.020
Why?
Fluorouracil
1
2009
46
0.020
Why?
Proteomics
1
2010
93
0.020
Why?
Carcinoma, Renal Cell
1
2009
49
0.020
Why?
Cisplatin
1
2009
53
0.020
Why?
Kidney Neoplasms
1
2009
80
0.020
Why?
Surgical Flaps
1
2009
51
0.020
Why?
Sutures
1
2008
52
0.020
Why?
Esophageal Diseases
1
2007
4
0.020
Why?
Ulcer
1
2007
7
0.020
Why?
Video Recording
2
1997
35
0.020
Why?
Maximum Tolerated Dose
1
2004
13
0.010
Why?
Statistics, Nonparametric
1
2004
129
0.010
Why?
Drug Administration Schedule
1
2004
166
0.010
Why?
Respiratory Function Tests
1
2003
36
0.010
Why?
Dose-Response Relationship, Drug
1
2004
352
0.010
Why?
Transplantation, Heterotopic
2
1993
7
0.010
Why?
Weight Loss
1
2003
130
0.010
Why?
Dogs
2
1993
193
0.010
Why?
Health Status
1
2003
226
0.010
Why?
Vital Capacity
1
1999
10
0.010
Why?
Pruritus
1
1999
9
0.010
Why?
Fentanyl
1
1999
23
0.010
Why?
Urinary Retention
1
1999
11
0.010
Why?
Cardiovascular Diseases
1
2003
373
0.010
Why?
Narcotics
1
1999
37
0.010
Why?
Thoracic Neoplasms
1
1997
9
0.010
Why?
Pain Measurement
1
1999
472
0.010
Why?
Abdominal Neoplasms
1
1997
15
0.010
Why?
Pericardial Window Techniques
1
1996
4
0.010
Why?
Treatment Failure
1
1997
163
0.010
Why?
Morbidity
1
1996
58
0.010
Why?
Radiotherapy
1
1995
34
0.010
Why?
Neoplasm Metastasis
1
1995
102
0.010
Why?
Recurrence
1
1995
322
0.010
Why?
Cyclosporine
1
1993
13
0.010
Why?
Electrodes, Implanted
1
1992
21
0.010
Why?
Monitoring, Physiologic
1
1992
77
0.010
Why?
Myocardium
1
1992
105
0.010
Why?
Immunosuppressive Agents
1
1992
140
0.010
Why?
Liptay's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (358)
Explore
_
Co-Authors (21)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_